Citation Impact
Citing Papers
Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group
2008
Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study
2009
Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors
2005
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
2006 StandoutScience
Magnetic Resonance Spectroscopy Identifies Neural Progenitor Cells in the Live Human Brain
2007 Science
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome
2010
Early Childhood Obesity Prevention Policies
2011
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
2001 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Simultaneous Activity of MRP1 and Pgp Is Correlated With In Vitro Resistance to Daunorubicin and With In Vivo Resistance in Adult Acute Myeloid Leukemia
1999
Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML)
2002
Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer
2000
Chloride-enhanced oxidation of organic contaminants by Cu(II)-catalyzed Fenton-like reaction at neutral pH
2017
Chimerism of the Transplanted Heart
2002 Standout
Large-area display textiles integrated with functional systems
2021 StandoutNature
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia
2003
Combination of Advanced Oxidation Processes and biological treatments for wastewater decontamination—A review
2010 Standout
P‐glycoprotein (PGP), lung resistance‐related protein (LRP) and multidrug resistance‐associated protein (MRP) expression in acute promyelocytic leukaemia
2000
Recent improvements in outcome for elderly patients with de novo acute myeloblastic leukemia
2001
Inhibition of MDR1 gene expression by chimeric HNA antisense oligonucleotides
2004
Acute Myeloid Leukemia in the Elderly
2008
Role of hMLH1 promoter hypermethylation in drug resistance to 5‐fluorouracil in colorectal cancer cell lines
2003
The Outcomes and Costs of Acute Myeloid Leukemia Among the Elderly
2002
The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis
2005
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study
2005
Cancer drug resistance: an evolving paradigm
2013 Standout
Graphene-based nanomaterials and their potentials in advanced drug delivery and cancer therapy
2018
Comparison of ‘sequential’ versus ‘standard’ chemotherapy as re‐induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML‐R trial
2001
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Recent developments in photocatalytic water treatment technology: A review
2010 Standout
Targeting multidrug resistance in cancer
2006 Standout
Participation in Cancer Clinical Trials
2004 Standout
Ratiometric multimodal chemosensors based on cubic silsesquioxanes for monitoring solvent polarity
2008
Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission
1998
Biology and management of relapsed acute myeloid leukaemia
2005
Therapy-Related Myelodysplastic Syndrome
2007
Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high‐risk myelodysplastic syndrome:
2006
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Modulation of Ocular Surface Glycocalyx Barrier Function by a Galectin-3 N-terminal Deletion Mutant and Membrane-Anchored Synthetic Glycopolymers
2013 StandoutNobel
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Adult Neurogenesis in the Mammalian Brain: Significant Answers and Significant Questions
2011 Standout
The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
2001
Considerations in the design and development of transport inhibitors as adjuncts to drug therapy
2003
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Modulation of drug resistance transporters as a strategy for treating myelodysplastic syndrome
2004
Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers
2002
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial
2001
Expression of Functional Markers in Acute Nonlymphoblastic Leukemia
2000
Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)
2002
Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome
2004
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
2003 Standout
Multidrug resistance in small cell lung cancer: Expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease
2006
Outcome of patients with acute myelogenous leukemia after second salvage therapy
2005
Development of Multidrug-Resistance Convertors: Sense or Nonsense?
2000
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Design, fabrication and control of soft robots
2015 StandoutNature
Mucins and mucin binding proteins in colorectal cancer
2003
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Mitoxantrone, Etoposide, and Cytarabine With or Without Valspodar in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome: A Phase III Trial (E2995)
2004
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
The Role of ABC Transporters in Clinical Practice
2003
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461
2006
Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study
2001
Tumour stem cells and drug resistance
2005 Standout
A Double-Blind Placebo-Controlled Trial of Granulocyte Colony-Stimulating Factor in Elderly Patients With Previously Untreated Acute Myeloid Leukemia: A Southwest Oncology Group Study (9031)
1998
Parallel Phase I Studies of Daunorubicin Given With Cytarabine and Etoposide With or Without the Multidrug Resistance Modulator PSC-833 in Previously Untreated Patients 60 Years of Age or Older With Acute Myeloid Leukemia: Results of Cancer and Leukemia Group B Study 9420
1999
MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients
2007
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
2003 Standout
Acute Myeloid Leukemia
2015 Standout
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720
2002
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Nanocarbons for Biology and Medicine: Sensing, Imaging, and Drug Delivery
2019
Multidrug resistance protein attenuates gemtuzumab ozogamicin–induced cytotoxicity in acute myeloid leukemia cells
2003
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999
Dose Escalation Studies of Cytarabine, Daunorubicin, and Etoposide With and Without Multidrug Resistance Modulation With PSC-833 in Untreated Adults With Acute Myeloid Leukemia Younger Than 60 Years: Final Induction Results of Cancer and Leukemia Group B Study 9621
2004
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999
Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse
2001
Expression of breast cancer resistance protein in blast cells from patients with acute leukemia
2000
Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B
2006
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
VX-710 (Biricodar) Increases Drug Retention and Enhances Chemosensitivity in Resistant Cells Overexpressing P-Glycoprotein, Multidrug Resistance Protein, and Breast Cancer Resistance Protein
2004
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Acute Myeloid Leukemia and Myelodysplastic Syndromes in Older Patients
2007
Expression of breast cancer resistance protein in blast cells from patients with acute leukemia
2000
Advanced Thermoelectric Design: From Materials and Structures to Devices
2020 Standout
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine
2001
A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group
2003
Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial
2001
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Classification of Intrinsically Disordered Regions and Proteins
2014 Standout
On computing three-finger force-closure grasps of polygonal objects
1995
Effect of system parameters and of inorganic salts on the decolorization and degradation of Procion H-exl dyes. Comparison of H2O2/UV, Fenton, UV/Fenton, TiO2/UV and TiO2/UV/H2O2 processes
2007
Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo
2000
Design and Kinematic Modeling of Constant Curvature Continuum Robots: A Review
2010 Standout
Recent Progress and Perspectives of Thermally Drawn Multimaterial Fiber Electronics
2019
Cyclosporin A Is a Broad-Spectrum Multidrug Resistance Modulator
2005
Single and Coupled Electrochemical Processes and Reactors for the Abatement of Organic Water Pollutants: A Critical Review
2015 Standout
Effect of Salinity on the Photo-Fenton Process
2007
The Physical Activity Guidelines for Americans
2018 Standout
Recent Developments in the Chemistry of Cubic Polyhedral Oligosilsesquioxanes
2010 Standout
P-glycoprotein plays a drug-efflux–independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway
2000
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
Universal robotic gripper based on the jamming of granular material
2010 Standout
Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies
2004
The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin
2004
Wearable thermoelectric generator to harvest body heat for powering a miniaturized accelerometer
2018
Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin
2001
Textile‐Based Thermoelectric Generators and Their Applications
2019
Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high‐risk myelodysplastic syndromes
2003
Age and acute myeloid leukemia
2006
P-Glycoprotein Inhibitor Valspodar (PSC 833) Increases the Intracellular Concentrations of Daunorubicin In Vivo in Patients With P-Glycoprotein–Positive Acute Myeloid Leukemia
2000
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
2009 Standout
Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study
2002
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Management of Acute Myelogenous Leukemia in the Elderly
2003
Carbon nanotube yarn based thermoelectric textiles for harvesting thermal energy and powering electronics
2019
ABC Transporters as Phenotypic Markers and Functional Regulators of Stem Cells
2002
Therapy-Related Acute Leukemia
2000
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Smart Textiles for Electricity Generation
2020
Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML
2014
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Works of I‐Ming Chen being referenced
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
1999
Locomotion and steering aspects in automation of colonoscopy. I. A literature review
1997
Biodegradation of Carbon Nanotubes, Graphene, and Their Derivatives
2017
Effect of chloride ions on the oxidation of aniline by Fenton's reagent
2005
Dual‐modality in vivo monitoring of subventricular zone stem cell migration and metabolism
2007
Finding antipodal point grasps on irregularly shaped objects
1993
Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study
1997
Patient and tumor characteristics of colon cancers with microsatellite instability: a population-based study.
2000
High-performance, flexible, and ultralong crystalline thermoelectric fibers
2017
Parental Ability to Discriminate the Weight Status of Children: Results of a Survey
2007
A Wearable Sensing System for Tracking and Monitoring of Functional Arm Movement
2010